Published in Proc Natl Acad Sci U S A on April 01, 1975
Identification of beta-adrenergic receptors in human lymphocytes by (-) (3H) alprenolol binding. J Clin Invest (1976) 2.58
Pathway and mechanism of drug binding to G-protein-coupled receptors. Proc Natl Acad Sci U S A (2011) 2.44
Catecholamine-induced subsensitivity of adenylate cyclase associated with loss of beta-adrenergic receptor binding sites. Proc Natl Acad Sci U S A (1975) 1.87
The receptor concept: pharmacology's big idea. Br J Pharmacol (2006) 1.25
Modulation of beta-adrenergic receptor signaling in heart failure and longevity: targeting adenylyl cyclase type 5. Heart Fail Rev (2010) 1.24
Distribution and function of beta-adrenoceptors in different chambers of the canine heart. Br J Pharmacol (1980) 1.19
Regulation of rabbit myometrial alpha adrenergic receptors by estrogen and progesterone. J Clin Invest (1977) 1.15
Catecholamine hormone receptor differences identified on 3T3 and simian virus-transformed 3T3 cells. Proc Natl Acad Sci U S A (1977) 0.94
Suppression of ventricular arrhythmias in man by d-propranolol independent of beta-adrenergic receptor blockade. J Clin Invest (1990) 0.90
Time course and extent of alpha 1-adrenoceptor density changes in rat heart after beta-adrenoceptor blockade. Br J Pharmacol (1989) 0.88
Affinity label for beta-adrenergic receptor in turkey erythrocytes. Proc Natl Acad Sci U S A (1976) 0.88
Cellular mechanisms of impaired adrenergic responsiveness in neonatal dogs. J Clin Invest (1981) 0.87
Alpha- and beta-adrenergic receptor subtypes properties, distribution and regulation. Drugs (1984) 0.86
Thyroid-hormone modulation of the number of beta-adrenergic receptors in rat fat-cell membranes. Biochem J (1978) 0.80
Non-co-ordinate development of beta-adrenergic receptors and adenylate cyclase in chick heart. Biochem J (1982) 0.80
Biochemical evidence for the dual action of labetalol on alpha- and beta-adrenoceptors. Br J Pharmacol (1978) 0.80
alpha-Adrenoceptor-mediated depletion of phosphatidylinositol 4, 5-bisphosphate inhibits activation of volume-regulated anion channels in mouse ventricular myocytes. Br J Pharmacol (2010) 0.77
Beta adrenergic receptor blockade of feline myocardium. Cardiac mechanics, energetics, and beta adrenoceptor regulation. J Clin Invest (1986) 0.77
A novel role of microglial NADPH oxidase in mediating extra-synaptic function of norepinephrine in regulating brain immune homeostasis. Glia (2015) 0.76
Effects of chronic administration of amitriptyline or mianserin on rat cardiac and central adrenoceptors. Br J Pharmacol (1985) 0.75
Ectopic beta-adrenergic receptor binding sites. possible molecular basis of aberrant catecholamine responsiveness of an adrenocortical tumor adenylate cyclase. J Clin Invest (1977) 0.75
Hydrocortisone increases the responsiveness of mast cells to beta-adrenergic agonists by an action distal to the beta-adrenoreceptors. Br J Exp Pathol (1979) 0.75
Induction by endogenous noradrenaline of an alpha 1-adrenoceptor-mediated positive inotropic effect in rabbit papillary muscles. Br J Pharmacol (1993) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
A highly sensitive adenylate cyclase assay. Anal Biochem (1974) 20.13
The pharmacological differentiation of adrenergic receptors. Ann N Y Acad Sci (1967) 3.65
Adenyl cyclase. III. The effect of catecholamines and choline esters on the formation of adenosine 3',5'-phosphate by preparations from cardiac muscle and liver. J Biol Chem (1962) 2.77
Peptide hormone binding to receptors: a review of direct studies in vitro. Metabolism (1973) 2.23
Beta-adrenergic receptor: stereospecific interaction of iodinated beta-blocking agent with high affinity site. Science (1974) 1.68
Stimulation of catecholamine-sensitive adenylate cyclase by 5'-guanylyl-imidodiphosphate. J Biol Chem (1974) 1.61
The binding characteristics and number of beta-adrenergic receptors on the turkey erythrocyte. Proc Natl Acad Sci U S A (1974) 1.41
Hormone action at the membrane level. II. The binding of epinephrine and glucagon to the rat liver plasma membrane. Biochim Biophys Acta (1970) 1.41
Noradrenaline binding and the search for catecholamine receptors. Nature (1974) 1.40
Uptake of propranolol by isolated guinea-pig atria. J Pharmacol Exp Ther (1967) 1.39
Identification of the cardiac beta-adrenergic receptor protein: solubilization and purification by affinity chromatography. Proc Natl Acad Sci U S A (1972) 1.38
Stereospecific (3H)(minus)-alprenolol binding sites, beta-adrenergic receptors and adenylate cyclase. Biochem Biophys Res Commun (1974) 1.30
A fraction of the ventricular myocardium that has the specificity of the cardiac beta-adrenergic receptor. Proc Natl Acad Sci U S A (1971) 1.17
Epinephrine binding to the catecholamine receptor and activation of the adenylate cyclase in erythrocyte membranes (hormone receptor- -adrenergic receptor-cyclic AMP-turkey). Proc Natl Acad Sci U S A (1972) 1.16
A beta-adrenergic receptor of the turkey erythrocyte. I. Binding of catecholamine and relationship to adenylate cyclase activity. J Biol Chem (1973) 1.15
Release of neurotransmitters and their interaction with receptors. Annu Rev Biochem (1972) 1.11
Specific binding of -adrenergic catecholamines to a subcellular fraction from cardiac muscle. J Biol Chem (1973) 1.09
Receptors and acceptors: a necessary distinction in hormone binding studies. Adv Cyclic Nucleotide Res (1974) 1.08
A beta-adrenergic receptor of the turkey erythrocyte. II. Characterization and solubilization of the receptor. J Biol Chem (1973) 1.05
Studies of fetal mouse hearts in organ culture: influence of prolonged exposure to triiodothyronine on cardiac responsiveness to isoproterenol, glucagon, theophylline, acetylcholine and dibutyryl cyclic 3',5'-adenosine monophosphate. J Pharmacol Exp Ther (1974) 1.03
Glucagon and epinephrine stimulation of adenyl cyclase in isolated rat liver plasma membranes. Biochem Biophys Res Commun (1969) 0.99
Commentary. Molecular pharmacology of beta-adrenergic receptors--a status report. Biochem Pharmacol (1974) 0.95
Heterogeneity of adenylate cyclase-coupled beta-adrenergic receptors. Biochem Pharmacol (1975) 0.94
Depressed adenyl cyclase activity in the failing guinea pig heart. Circ Res (1969) 0.89
Supersensitivity of the chronically denervated feline heart. Am J Physiol (1968) 0.89
Effect of phenylephrine on cardiac contractility and adenyl cyclase activity. Can J Physiol Pharmacol (1971) 0.89
Effects of adrenergic agonists and antagonists on adenylate cyclase activity of dog heart and liver. J Pharmacol Exp Ther (1972) 0.88
(3H)-Propranolol binding sites in myocardial membranes: nonidentity with beta adrenergic receptors. Mol Pharmacol (1974) 0.85
Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res (1994) 8.57
Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. Science (1999) 7.57
The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science (1992) 7.49
Cloning of the gene and cDNA for mammalian beta-adrenergic receptor and homology with rhodopsin. Nature (1986) 7.06
Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J Exp Med (1999) 6.09
A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. J Biol Chem (1980) 6.06
Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med (1986) 6.05
A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc Natl Acad Sci U S A (1998) 5.94
Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes. Proc Natl Acad Sci U S A (1977) 5.87
Model systems for the study of seven-transmembrane-segment receptors. Annu Rev Biochem (1991) 5.70
G protein-coupled receptor kinases. Annu Rev Biochem (1998) 5.53
Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A. Nature (1997) 5.31
Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3. Science (2000) 5.20
Distinct phosphotyrosines on a growth factor receptor bind to specific molecules that mediate different signaling pathways. Cell (1992) 5.09
Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin. Science (2001) 5.05
Direct activation of the serine/threonine kinase activity of Raf-1 through tyrosine phosphorylation by the PDGF beta-receptor. Cell (1989) 4.86
PDGF beta-receptor stimulates tyrosine phosphorylation of GAP and association of GAP with a signaling complex. Cell (1990) 4.85
Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor. Science (1994) 4.84
cDNA cloning of a novel 85 kd protein that has SH2 domains and regulates binding of PI3-kinase to the PDGF beta-receptor. Cell (1991) 4.76
Structural and functional diversity in the FGF receptor multigene family. Adv Cancer Res (1993) 4.67
Cloning of the cDNA for the human beta 1-adrenergic receptor. Proc Natl Acad Sci U S A (1987) 4.66
cDNA for the human beta 2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor. Proc Natl Acad Sci U S A (1987) 4.61
Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds. Proc Natl Acad Sci U S A (2001) 4.56
beta-Arrestin: a protein that regulates beta-adrenergic receptor function. Science (1990) 4.53
A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature (1998) 4.52
A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model. J Biol Chem (1993) 4.52
Role of phosphatidylinositol kinase in PDGF receptor signal transduction. Science (1989) 4.21
Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science (1997) 4.19
Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. Science (1995) 4.18
Signalling by receptor tyrosine kinases. Annu Rev Biochem (1993) 4.11
Turning off the signal: desensitization of beta-adrenergic receptor function. FASEB J (1990) 4.05
Enhanced morphine analgesia in mice lacking beta-arrestin 2. Science (1999) 4.04
Purification and complementary DNA cloning of a receptor for basic fibroblast growth factor. Science (1989) 3.83
Membrane localization of phosphatidylinositol 3-kinase is sufficient to activate multiple signal-transducing kinase pathways. Mol Cell Biol (1996) 3.82
Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. J Clin Invest (1988) 3.76
Regulation of transmembrane signaling by receptor phosphorylation. Cell (1987) 3.74
Molecular mechanisms of receptor desensitization using the beta-adrenergic receptor-coupled adenylate cyclase system as a model. Nature (1985) 3.74
Chimeric alpha 2-,beta 2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity. Science (1988) 3.60
A specific product of phosphatidylinositol 3-kinase directly activates the protein kinase Akt through its pleckstrin homology domain. Mol Cell Biol (1997) 3.52
Cloning, sequencing, and expression of the gene coding for the human platelet alpha 2-adrenergic receptor. Science (1987) 3.47
Role of beta gamma subunits of G proteins in targeting the beta-adrenergic receptor kinase to membrane-bound receptors. Science (1992) 3.45
Ras-dependent induction of cellular responses by constitutively active phosphatidylinositol-3 kinase. Science (1995) 3.42
Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence. Nature (2000) 3.42
The beta2-adrenergic receptor interacts with the Na+/H+-exchanger regulatory factor to control Na+/H+ exchange. Nature (1998) 3.41
Beta-adrenergic receptor kinase: identification of a novel protein kinase that phosphorylates the agonist-occupied form of the receptor. Proc Natl Acad Sci U S A (1986) 3.38
An intronless gene encoding a potential member of the family of receptors coupled to guanine nucleotide regulatory proteins. Nature (1987) 3.33
Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med (1995) 3.32
International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol Rev (1994) 3.26
Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes. Mol Pharmacol (1982) 3.23
Activation of the cloned muscarinic potassium channel by G protein beta gamma subunits. Nature (1994) 3.21
A phosphatidylinositol-3 kinase binds to platelet-derived growth factor receptors through a specific receptor sequence containing phosphotyrosine. Mol Cell Biol (1991) 3.20
Molecular cloning and expression of the cDNA for the hamster alpha 1-adrenergic receptor. Proc Natl Acad Sci U S A (1988) 3.18
The function of KGF in morphogenesis of epithelium and reepithelialization of wounds. Science (1994) 3.07
Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc Natl Acad Sci U S A (1993) 3.01
Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest (1993) 2.97
Beta-arrestin2, a novel member of the arrestin/beta-arrestin gene family. J Biol Chem (1992) 2.97
Palmitoylation of the human beta 2-adrenergic receptor. Mutation of Cys341 in the carboxyl tail leads to an uncoupled nonpalmitoylated form of the receptor. J Biol Chem (1989) 2.95
A family of receptors coupled to guanine nucleotide regulatory proteins. Biochemistry (1987) 2.91
Binding of G protein beta gamma-subunits to pleckstrin homology domains. J Biol Chem (1994) 2.91
Large induction of keratinocyte growth factor expression in the dermis during wound healing. Proc Natl Acad Sci U S A (1992) 2.89
Molecular basis for interactions of G protein betagamma subunits with effectors. Science (1998) 2.88
beta-Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking. Proc Natl Acad Sci U S A (2001) 2.86
Regulation of tyrosine kinase cascades by G-protein-coupled receptors. Curr Opin Cell Biol (1999) 2.86
An alternative to SH2 domains for binding tyrosine-phosphorylated proteins. Science (1994) 2.80
Cloning and expression of a human kidney cDNA for an alpha 2-adrenergic receptor subtype. Proc Natl Acad Sci U S A (1988) 2.78
Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/beta -catenin signaling is activated in human colon tumors. Proc Natl Acad Sci U S A (2001) 2.77
Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice. Proc Natl Acad Sci U S A (1998) 2.76
Regulation of chemotaxis by the platelet-derived growth factor receptor-beta. Nature (1994) 2.71
Platelet-derived growth factor (PDGF)-dependent association of phospholipase C-gamma with the PDGF receptor signaling complex. Mol Cell Biol (1990) 2.71
Oscillatory and steady laminar shear stress differentially affect human endothelial redox state: role of a superoxide-producing NADH oxidase. Circ Res (1998) 2.70
c-myc gene expression is stimulated by agents that activate protein kinase C and does not account for the mitogenic effect of PDGF. Cell (1985) 2.69
PAR-1 is a Dishevelled-associated kinase and a positive regulator of Wnt signalling. Nat Cell Biol (2001) 2.69
A C-terminal motif found in the beta2-adrenergic receptor, P2Y1 receptor and cystic fibrosis transmembrane conductance regulator determines binding to the Na+/H+ exchanger regulatory factor family of PDZ proteins. Proc Natl Acad Sci U S A (1998) 2.68
Bridging of beta-catenin and glycogen synthase kinase-3beta by axin and inhibition of beta-catenin-mediated transcription. Proc Natl Acad Sci U S A (1998) 2.66
Optical properties of the metals Al, Co, Cu, Au, Fe, Pb, Ni, Pd, Pt, Ag, Ti, and W in the infrared and far infrared. Appl Opt (1983) 2.65
Receptor-tyrosine-kinase- and G beta gamma-mediated MAP kinase activation by a common signalling pathway. Nature (1995) 2.64
Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy. Science (1998) 2.64
The human fibroblast growth factor receptor genes: a common structural arrangement underlies the mechanisms for generating receptor forms that differ in their third immunoglobulin domain. Mol Cell Biol (1991) 2.63
Platelet-derived growth factor receptors form a high affinity state in membrane preparations. Kinetics and affinity cross-linking studies. J Biol Chem (1984) 2.61
Identification of beta-adrenergic receptors in human lymphocytes by (-) (3H) alprenolol binding. J Clin Invest (1976) 2.58
Evidence for phosphatidylinositol 3-kinase as a regulator of endocytosis via activation of Rab5. Proc Natl Acad Sci U S A (1995) 2.58
International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors: consensus update. Pharmacol Rev (1995) 2.53
Cellular expression of the carboxyl terminus of a G protein-coupled receptor kinase attenuates G beta gamma-mediated signaling. J Biol Chem (1994) 2.53
Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature (1991) 2.53
Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes. Proc Natl Acad Sci U S A (2001) 2.52
Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3. Proc Natl Acad Sci U S A (1991) 2.48
Point mutation of an FGF receptor abolishes phosphatidylinositol turnover and Ca2+ flux but not mitogenesis. Nature (1992) 2.46
Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells. J Biol Chem (1999) 2.46
Essential role for G protein-coupled receptor endocytosis in the activation of mitogen-activated protein kinase. J Biol Chem (1998) 2.45
The beta(2)-adrenergic receptor mediates extracellular signal-regulated kinase activation via assembly of a multi-receptor complex with the epidermal growth factor receptor. J Biol Chem (2000) 2.44
Multiple pathways of rapid beta 2-adrenergic receptor desensitization. Delineation with specific inhibitors. J Biol Chem (1990) 2.42
Adenylate cyclase-coupled beta-adrenergic receptors: structure and mechanisms of activation and desensitization. Annu Rev Biochem (1983) 2.40
Gastroesophageal reflux-induced bronchoconstriction. Is microaspiration a factor? Chest (1995) 2.40
Role of c-Src tyrosine kinase in G protein-coupled receptor- and Gbetagamma subunit-mediated activation of mitogen-activated protein kinases. J Biol Chem (1996) 2.39
Beta-adrenergic receptors: biochemical mechanisms of physiological regulation. Physiol Rev (1984) 2.38
Coupling of beta2-adrenoceptor to Gi proteins and its physiological relevance in murine cardiac myocytes. Circ Res (1999) 2.37
Oscillatory shear stress stimulates adhesion molecule expression in cultured human endothelium. Circ Res (1998) 2.37
Classical and new roles of beta-arrestins in the regulation of G-protein-coupled receptors. Nat Rev Neurosci (2001) 2.36